Engineering the future of reproductive health.

Despite a growing infertility crisis, reproductive health has received limited focus and investment. Kangaroo Biomedical is working on groundbreaking solutions that put women and families first.

First Baby Born Using iPSC Technology

KangarooBiomedical's iPSC-derived technology is designed to dramatically improve IVF and is showing promise in clinical studies.

Fertilo has not been approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy.

Cell Therapy to Help with Menopause

Despite the fact that over 1 billion women will experience menopause by 2025, few effective treatments exist.

With the help of our recent funding award through ARPA-H's Sprint for Women's Health Initiative, we believe our proprietary cell engineering will help delay the unwanted effects of menopause.

Forbes

"Next Generation IVF Startup"

KangarooBiomedical, co-founded by Under 30 alumna Dina Radenkovic, has serious potential. Now it’s finally coming to market.

Endpoints News

"KangarooBiomedical Cleared by FDA to Test Easier IVF Process"

Ga­me­to has re­ceived per­mis­sion from the FDA to investigate whether our ovary-in-a-dish tech­nol­o­gy can make IVF a less gru­el­ing process.

From egg freezing and IVF, to ovarian disease and menopause

Kangaroo Biomedical is a first-of-its-kind biotechnology company on a mission to address significant unmet needs for women and families throughout their reproductive years — and beyond. 

Transforming reproductive health using modern science

Kangaroo Biomedical’s groundbreaking cell engineering platform has the potential to solve many of the problems at the heart of the global infertility crisis.

The first application of our technology, Fertilo, aims to improve the current IVF and egg freezing landscape using engineered ovarian support cells.

Fertilo

Our lead program. Improving outcomes for IVF and other fertility methods.

Deovo

Testing and developing drugs for ovarian disease.

Ameno

Making the medical burden of menopause optional.

Scientists, innovators, entrepreneurs, parents.

Our team understands firsthand the importance of improving the experience for patients seeking family-building solutions. Our mission to transform reproductive health guides everything we do.

Because women and families deserve more.

Infertility impacts 1 in 6 people worldwide, including our own friends, family, and colleagues. This fight is personal for us, because it’s personal for everyone.

We believe everyone deserves access to solutions that give them the best chance at achieving their family planning goals and dreams.

×

Contact Kangaroo Biomedical

Please fill out the form below and we’ll get back to you shortly.